Methods for the treatment of male and female sexual dysfunction
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 17, 2005
app pub date -
Aug 2, 2004
filing date -
Jul 31, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods for the treatment of female sexual dysfunction, including treatment of associated postmenopausal symptoms, are provided using very low doses of 17.beta.-[(1-methyl-1,4-dihydro-3-pyridinyl)carbonyloxy]estr-a-1,3,5(10)-trien-3-ol, also known as E.sub.2-CDS, which do not elevate average steady-state peripheral estradiol levels to above about 50-60 pg/ml. Also, methods for the treatment of male sexual dysfunction are provided using very low doses of E.sub.2-CDS which do not substantially elevate average peripheral estradiol levels to above average normal peripheral levels in the male mammal.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully